Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Fayetteville › NPI 1639172869
Hospital

Cumberland County Hospital System INC

Cumberland County Hospital System INC was paid $75.79M by Medicaid between Jan 2018 and Dec 2024, across 243 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.

33Billing provider infoCUMBERLAND COUNTY HOSPITAL SYSTEM INC
FAYETTEVILLE, NC 28304
33aNPI1639172869assigned 05/23/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$75.79M
24GClaims2,023,871
24DCodes billed243
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in North Carolina

Rank by total paid#4 of 92
Median peer was paid$11.47M
This provider vs. median6.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official FISER, JOSEPH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018223,896$9.02M
2019344,896$8.46M
2020235,340$6.38M
2021270,115$9.03M
2022312,196$12.47M
2023330,523$14.35M
2024incomplete306,905$16.08M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 29% 140,809 120,214 $22.14M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 20% 70,377 57,580 $14.97M
99282 Emergency department visit for the evaluation and management, low to moderate severity 11% 100,258 89,223 $8.40M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 3.8% 70,517 60,979 $2.92M
G0378 Hospital observation service, per hour 3.5% 10,001 6,091 $2.67M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 3.3% 16,736 14,987 $2.53M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.0% 5,533 4,461 $1.55M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.7% 59,572 42,494 $1.26M
70450 Computed tomography, head or brain; without contrast material 1.4% 5,134 4,115 $1.07M
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 1.3% 5,579 5,143 $1.02M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.3% 21,574 17,336 $958K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1.2% 37,966 32,560 $917K
231 more codes
99214 Doctor's office visit, returning patient (more involved) 1.2% 33,726 $885K
80053 Comprehensive metabolic panel 1.1% 114,146 $871K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1.1% 3,558 $796K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 6,810 $674K
71046 Radiologic examination, chest; 2 views <1% 16,523 $612K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 29,056 $554K
85027 <1% 99,915 $507K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 11,834 $493K
J3490 Unclassified drugs <1% 257,738 $488K
87428 <1% 6,085 $480K
76819 Fetal biophysical profile; without non-stress testing <1% 6,909 $479K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 8,083 $477K
81025 <1% 55,668 $404K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 21,731 $391K
71045 Radiologic examination, chest; single view <1% 15,154 $333K
36415 Collection of venous blood by venipuncture <1% 178,134 $309K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 5,396 $299K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 49,212 $291K
84484 <1% 45,675 $283K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 17,666 $265K
96375 Therapeutic injection; each additional sequential IV push <1% 9,937 $250K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 1,780 $247K
80048 Basic metabolic panel (calcium, ionized) <1% 33,625 $216K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 210 $205K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 6,335 $198K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 385 $180K
83036 Hemoglobin; glycosylated (A1C) <1% 16,223 $174K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 4,059 $158K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 12,080 $142K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 272 $137K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 5,589 $136K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 5,590 $136K
81001 <1% 43,803 $133K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,782 $129K
87486 <1% 3,562 $126K
87581 <1% 3,559 $124K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,458 $112K
82947 <1% 29,056 $111K
83690 <1% 17,729 $108K
87070 <1% 10,747 $105K
A9270 Non-covered item or service <1% 106,881 $102K
99205 Prolong outpt/office vis <1% 1,122 $92K
0002A <1% 1,542 $82K
84443 Thyroid stimulating hormone (TSH) <1% 5,225 $80K
96361 Intravenous infusion, hydration; each additional hour <1% 817 $80K
0001A <1% 1,575 $75K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 101 $67K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,398 $65K
93017 <1% 453 $56K
74018 <1% 1,008 $56K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 2,054 $52K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 3,696 $52K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 887 $50K
J1453 Injection, fosaprepitant, 1 mg <1% 377 $50K
87088 <1% 5,254 $45K
99204 Doctor's office visit, new patient (more involved) <1% 765 $44K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 941 $40K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,076 $40K
J2469 Injection, palonosetron hcl, 25 mcg <1% 466 $37K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 8,159 $37K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 208 $36K
81002 <1% 12,217 $34K
81003 <1% 12,190 $34K
96376 <1% 416 $32K
J7120 Ringers lactate infusion, up to 1000 cc <1% 4,230 $32K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,267 $31K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,233 $31K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 1,499 $30K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 1,872 $29K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 104 $29K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 935 $29K
80061 Lipid panel <1% 2,876 $28K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,869 $28K
84439 <1% 2,802 $27K
84702 <1% 2,717 $27K
76801 <1% 169 $26K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,118 $25K
83735 <1% 5,222 $24K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 426 $23K
88307 <1% 130 $23K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 385 $23K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 911 $23K
82728 <1% 2,038 $22K
J2785 Injection, regadenoson, 0.1 mg <1% 277 $22K
76820 <1% 548 $22K
80320 <1% 839 $20K
96367 <1% 774 $19K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 48 $17K
85730 <1% 4,534 $16K
87400 <1% 1,051 $15K
85018 <1% 5,409 $13K
11043 <1% 104 $12K
90837 Psychotherapy session, about an hour <1% 346 $12K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 99 $12K
85610 <1% 5,335 $12K
87807 <1% 611 $11K
86592 <1% 2,436 $11K
J7030 Infusion, normal saline solution , 1000 cc <1% 2,922 $11K
72125 Computed tomography, cervical spine; without contrast material <1% 48 $11K
0003A <1% 222 $11K
99244 Office or other outpatient consultation, moderate to high complexity <1% 750 $9K
99241 <1% 1,186 $9K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 13,263 $9K
99215 Doctor's office visit, returning patient (complex) <1% 149 $9K
J7510 Prednisolone oral, per 5 mg <1% 2,945 $8K
0071A <1% 143 $8K
83550 <1% 1,291 $8K
82077 <1% 5,729 $7K
99245 <1% 338 $7K
90834 Psychotherapy session, about 45 minutes <1% 271 $6K
86850 <1% 510 $6K
94664 <1% 189 $6K
43264 <1% 16 $6K
87420 <1% 446 $6K
80143 <1% 3,671 $6K
87210 <1% 1,236 $5K
80179 <1% 3,534 $5K
83615 <1% 1,717 $5K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 742 $5K
11044 <1% 28 $5K
C1769 Guide wire <1% 52 $5K
86376 <1% 277 $5K
0072A <1% 78 $5K
80329 <1% 362 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 521 $4K
82607 <1% 258 $4K
J2704 Injection, propofol, 10 mg <1% 837 $4K
43259 <1% 18 $4K
95811 <1% 12 $4K
86762 <1% 227 $4K
86787 <1% 250 $3K
82550 <1% 919 $3K
94644 <1% 103 $3K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 19 $3K
29581 <1% 75 $3K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 71 $3K
86360 <1% 119 $3K
83021 <1% 142 $3K
86481 <1% 32 $3K
90847 Family psychotherapy with the patient present, 50 minutes <1% 135 $2K
94760 <1% 132 $2K
86900 <1% 648 $2K
86901 <1% 647 $2K
90791 Psychiatric diagnostic evaluation <1% 63 $2K
99402 <1% 210 $2K
74330 <1% 17 $2K
J1650 Injection, enoxaparin sodium, 10 mg <1% 160 $2K
80074 <1% 50 $2K
0054A <1% 43 $2K
73130 <1% 34 $2K
87340 <1% 181 $2K
87205 <1% 390 $2K
J3480 Injection, potassium chloride, per 2 meq <1% 203 $2K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 19 $2K
93296 <1% 75 $2K
87077 <1% 263 $2K
85007 <1% 747 $2K
C1877 Stent, non-coated/non-covered, without delivery system <1% 16 $2K
0353U <1% 157 $2K
99203 Doctor's office visit, new patient (routine) <1% 62 $2K
90832 Psychotherapy session, about 30 minutes <1% 93 $1K
84681 <1% 66 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 678 $1K
73090 <1% 14 $1K
87536 <1% 141 $1K
96417 <1% 35 $1K
84145 <1% 38 $1K
82677 <1% 43 $1K
86140 <1% 151 $1K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 50 $1K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 13 $1K
86255 <1% 69 $1K
83516 <1% 69 $967.72
73562 <1% 21 $905.71
83525 <1% 47 $860.92
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 206 $850.73
73610 <1% 12 $843.04
0004A <1% 20 $832.80
0052A <1% 20 $828.67
86336 <1% 43 $785.21
82784 <1% 69 $784.97
82105 <1% 43 $783.36
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 37 $751.92
52310 <1% 12 $712.76
0053A <1% 13 $711.79
96402 <1% 33 $686.71
82043 <1% 129 $686.10
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 329 $681.19
72100 <1% 13 $680.68
83605 <1% 85 $680.38
J3010 Injection, fentanyl citrate, 0.1 mg <1% 152 $671.48
82570 <1% 129 $613.00
82553 <1% 109 $603.26
J2270 Injection, morphine sulfate, up to 10 mg <1% 198 $585.70
99243 <1% 51 $579.90
74019 <1% 12 $566.86
96415 <1% 12 $551.34
82950 <1% 91 $528.46
84466 <1% 64 $518.53
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 28 $507.38
J2060 Injection, lorazepam, 2 mg <1% 278 $499.64
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 27 $486.85
G0008 Administration of influenza virus vaccine <1% 35 $359.53
82180 <1% 39 $320.32
87040 <1% 24 $308.64
83880 <1% 16 $292.22
82248 <1% 106 $276.80
J3105 Injection, terbutaline sulfate, up to 1 mg <1% 17 $248.91
J1630 Injection, haloperidol, up to 5 mg <1% 67 $231.42
83540 <1% 46 $218.16
82565 <1% 64 $209.82
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 103 $203.72
95886 <1% 12 $170.04
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 254 $169.30
83921 <1% 14 $168.39
84100 <1% 87 $163.14
85014 <1% 93 $147.25
87220 <1% 28 $122.13
84156 <1% 18 $119.10
86403 <1% 12 $114.30
J0690 Injection, cefazolin sodium, 500 mg <1% 30 $109.45
87186 <1% 24 $96.93
J7060 5% dextrose/water (500 ml = 1 unit) <1% 39 $79.69
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 18 $59.53
83986 <1% 13 $47.64
51798 <1% 30 $40.28
90686 <1% 54 $3.22
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 0% 289 $0.00
36591 0% 33 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 610 $0.00
01967 Neuraxial labor analgesia/anesthesia for planned vaginal delivery 0% 85 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFISER, JOSEPH (VP MANAGED CARE AND REVENUE CYCLE)
Same official

Other billing entities under FISER, JOSEPH

Full network →
ProviderLocationPaid
CFVHS Ed PhysiciansFayetteville, NC$26.24M
Hoke Healthcare LLCRaeford, NC$24.80M
Harnett Health System, INC.Dunn, NC$23.37M
Cumberland County Hospital System INCFayetteville, NC$19.73M
Cumberland County Hospital System INCFayetteville, NC$8.69M
Cumberland County Hospital System INCFayetteville, NC$8.04M
Bladen Healthcare LLCElizabethtown, NC$7.78M
Cumberland County Hospital System INCFayetteville, NC$7.71M
Harnett Health System INCDunn, NC$6.94M
Cumberland County Hospital System INCFayetteville, NC$6.61M
Bladen Healthcare, LLCElizabethtown, NC$5.01M
Cumberland County Hospital System INCFayetteville, NC$4.82M
Hoke Healthcare, LLCRaeford, NC$2.73M
Cumberland County Hospital System INCFayetteville, NC$2.70M
CFV Specialty Care Billing Services, LLCFayetteville, NC$2.33M
Bladen Healthcare LLCElizabethtown, NC$2.14M
CFV Express Care Billing Services LLCFayetteville, NC$1.43M
Hoke Healthcare, LLCRaeford, NC$1.38M
Cumberland County Hospital System INCFayetteville, NC$1.34M
Cumberland County Hospital System INCRaeford, NC$953K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.